18 insiders have filed at RXRX since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Borgeson Blake | Director | 6.26M | 1.183% | 43 sells $7.7M | |
| Bogue Zachary | Director | 3.74M | 0.706% | ||
| Li Dean Y | Director | 3.22M | 0.609% | 2 sells $396k | |
| Khan Najat | CEO And President | 2.26M | 0.427% | 3 sells $845k | |
| Secora Michael | Chief Financial Officer | 1.49M | 0.281% | 37 sells $5.9M | |
| Taylor Ben R | Chief Financial Officer | 1.18M | 0.223% | 3 sells $158k | |
| Hallett David | Chief Scientific Officer | 1.10M | 0.207% | ||
| Gibson Christopher | Director | 906.6k | 0.171% | 85 sells $19.7M | |
| Marriott Tina | President And COO | 506.9k | 0.096% | 20 sells $857k | |
| Mauro David J | Chief Medical Officer | 225.4k | 0.043% | ||
| Dar Zavain | Director | 142.3k | 0.027% | 1 sells $181k | |
| Virani Shafique | Chief Business Officer | 136.7k | 0.026% | 10 sells $2.3M | |
| Michor Franziska | Director | 127.1k | 0.024% | ||
| Hershberg Robert | Director | 73.7k | 0.014% | ||
| Burrell Terry-Ann | Director | 71.3k | 0.013% | 5 sells $1.4M | |
| Chavez R. Martin | Director | 60.1k | 0.011% | ||
| Bumpus Namandje | Director | 47.6k | <0.01% | ||
| Sun Elaine D | Director | 47.6k | <0.01% |
Full register at boothcheck.com/insiders/RXRX. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.